基于对肺腺癌患者单细胞测序的伪时间分析的瘤预后风险分层

Huanle Jin1,2, Huandi Jin1,2, Ting Wu1,2

  • 1Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.

PubMed
概括

这项研究确定了伪时间差异基因 (PTDGs),以根据预后分层肺腺癌 (LUAD) 患者. 这些PTDG显示出改善LUAD风险评估的生物标志物的潜力.